CERECYTE PRESIDIO PC4180933-30Recalls & reported problems
Medos International Sàrl · PRESIDIO microcoil PRESIDIO 18 CERECYTE Coil 9mm x 33cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
All models of CERECYTE PRESIDIO (16)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00878528003212), received between Jan 2, 2019 and Mar 9, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Difficult to Remove1
- Migration1
- Positioning Problem1
- Premature Separation1
- Separation Failure1
- Stretched1
Patient problems
- Infarction, Cerebral1
- No Clinical Signs, Symptoms or Conditions1
- No Code Available1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 9, 2021Separation Failure; Separation Failure
THE HEALTHCARE PROFESSIONAL REPORTED THAT DURING THE STENT-ASSISTED ANEURYSM EMBOLIZATION PROCEDURE, THE 9MM X 33CM PRESIDIO 18 CERECYTE COIL (PC418093330 / K10442) WAS DELIVERED TO THE TARGET POSITION BUT IT WAS REPORTED THAT THE COIL COULD NOT BE DETACHED. THE PHYSICIAN REMOVED THE COMPLAINT COIL FROM THE PATIENT AND SWITCHED TO ANOTHER COIL TO COMPLETE THE PROCEDURE. THERE WAS NO REPORT OF ANY PATIENT ADVERSE EVENT OR COMPLICATION. A PHOTO OF THE COMPLAINT DEVICE WAS INCLUDED IN THE COMPLAINT FILE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11448748 ↗InjuryJan 2, 2019Difficult to Remove; Stretched; Positioning Problem; Migration; Premature Separation; Difficult to Remove; Stretched; Positioning Problem; Migration; Premature Separation
AS REPORTED BY A HEALTHCARE PROFESSIONAL, A FAILURE OF THE INTERNAL COIL RESISTANT MATERIAL OCCURRED DURING USE OF A 9MM X 33CM PRESIDIO 18 CERE (PC418093330/C40834) THERMO-MECHANICAL COIL. IT WAS REPORTED THAT: "THERE ARE COMMENTS, WHICH STATE THAT IT WAS A PREMATURE DETACHMENT, BUT THE SURGEON FEELS THAT IT WASN¿T A PREMATURE DETACHMENT, BUT A FAILURE OF THE INTERNAL COIL RESISTANT MATERIAL, WHICH HAD SNAPPED, CAUSING A PART OF A COIL TO DISLODGE." NO PATIENT COMPLICATIONS OCCURRED AS A RESULT OF THE EVENT. THE COIL REMAINS IMPLANTED IN THE PATIENT AND IS THUS NOT AVAILABLE FOR EVALUATION. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Infarction, Cerebral; No Code Available; No Consequences Or Impact To Patient
MAUDE report 8207769 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page